NIH-funded research R01 grant

Bifunctional mucinase and personalized gut microbiota in cholera infection

Official title: The role of a bifunctional mucinase in modulating personalized gut microbiota-Vibrio cholerae interactions during infection

Funded at University of Pennsylvania · NIH-11348224 · Data updated 2026-11-12

A study in people and models to understand how a cholera bacterium interacts with the gut mucous layer and the individual’s own gut microbes during infection.

More Microbiota research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startJune 1, 2023
Project endMay 31, 2028
Funding year2026
Award (this year)$741,908
NIH project number5R01AI178908-04
Project IDNIH-11348224 on NIH RePORTER

Who could benefit from this research

Could help

People with or at risk for cholera might benefit from future diagnostics or therapies informed by how their gut microbiome interacts with the pathogen.

Less likely to help

Healthy individuals without exposure or risk for cholera are unlikely to benefit from this research.

What this research studies

This project looks at how Vibrio cholerae uses a mucin-degrading enzyme to grow in the intestinal mucus and how this process varies with a person’s gut microbiome. Researchers will use ex vivo tissue cultures and live, germ-free mouse models carrying human-like microbiomes to test bacterial growth and mucus responses. By comparing normal and mutant bacteria that lack the TagA enzyme, they aim to map how mucus metabolism shapes infection outcomes in different people. The goal is to reveal why some individuals are more susceptible to severe infection and how microbiome context influences disease.

Why it matters

Potential benefit: Understanding personalized factors that influence cholera infection could lead to targeted prevention or treatment strategies based on an individual’s gut microbiome.

How similar studies have gone: Previous work shows that mucus and microbiome interactions affect pathogen colonization, but this study adds a personalized, mucinase-centered mechanism.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Zhu, Jun — University of Pennsylvania
  • Study coordinator: Zhu, Jun

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.